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Abstract
Anxiety is common in children with ASD; however, the burden of specific anxiety disorders for adults with ASD is under-
researched. Using the Stockholm Youth Cohort, we compared anxiety disorder diagnoses among autistic adults (n = 4049), 
with or without intellectual disability, and population controls (n = 217,645). We conducted additional sibling analyses. Anxi-
ety disorders were diagnosed in 20.1% of adults with ASD compared with 8.7% of controls (RR = 2.62 [95% CI 2.47–2.79]), 
with greatest risk for autistic people without intellectual disability. Rates of almost all individual anxiety disorders were 
raised, notably obsessive–compulsive disorder and phobic anxiety disorders. Anxiety disorders were more common in full 
siblings and half-siblings of people with ASD. The implications of this are explored.
Keywords Autism spectrum disorder · Intellectual disability · Anxiety · Mental health · Epidemiology
Introduction
Autism spectrum disorders (ASD) are characterised by 
early-onset difficulties in social interaction, communication 
and restricted, repetitive patterns of interests and behaviour 
(Lai et al. 2014). At least 1% of the population have ASD 
(Brugha et al. 2016; Idring et al. 2015; Fombonne 2009). 
Despite a growing number of clinical and epidemiologi-
cal studies, there is still limited understanding of the adult 
outcomes of people with ASD. Psychiatric comorbidity 
in ASD is associated with worse outcomes for individuals 
(Gillberg et al. 2016) and a greater burden for their fami-
lies and society (Baxter et al. 2015; Buescher et al. 2014). 
Understanding the psychiatric comorbidities which affect 
adults with ASD is therefore essential to the planning of 
community services and optimising quality of life (Bakken 
et al. 2010; Charlot et al. 2008; Gillott and Standen 2007; La 
Malfa et al. 2007; Bradley and Bolton 2006).
While anxiety disorders are known to be common in 
children and adolescents with ASD (van Steensel et al. 
2011; White et al. 2009; Vasa and Mazurek 2015) less is 
known about the prevalence of anxiety disorders in adult 
populations. Studies to date of adults provide an inconsist-
ent account with prevalence estimates ranging between 28% 
and 77% and are limited by differences in methodological 
design, small sample size (Mazefsky et al. 2008; Tani et al. 
2012), recruitment of selected samples from secondary ser-
vices, or lack of a valid comparison group (Tani et al. 2012; 
Kanai et al. 2011; Bakken et al. 2010; Hutton et al. 2008; 
Buck et al. 2014; Hofvander et al. 2009; Russell et al. 2016; 
Lever and Geurts 2016). The existing evidence is therefore 
difficult to generalise and may be subject to confounding 
and selection bias.
The largest study of this topic to date used data from a 
medical insurance registration database in California and 
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found that 29% of 1507 adults with a diagnosis of ASD also 
had an anxiety disorder diagnosed compared with 9% of a 
non-autistic reference population (adjusted odds ratio 3.69 
[95% CI 3.11 to 4.36]) (Croen et al. 2015). However, other 
than obsessive–compulsive disorders (OCD), the study 
did not identify subtypes of anxiety and did not adjust for 
potentially important confounders such as parental mental 
illness or socioeconomic characteristics. A large Danish 
study reported over a two-fold incidence of OCD in indi-
viduals who had been diagnosed with ASD compared with 
those who had not (incidence rate ratio 2.18 [95% CI 1.91 
to 2.48]) (Meier et al. 2015). Apart from OCD there have 
been no known large studies of specific anxiety disorders in 
adults with ASD.
It has been suggested that common mental disorders 
could be more prevalent in individuals with ASD without 
intellectual disability (ID), because they may have more 
insight into their problems. This pattern has been observed 
for depression (Rai et al. 2018) and for OCD (Meier et al. 
2015) in higher functioning individuals with ASD. To date, 
studies of the prevalence of other anxiety disorders in adults 
with autism and ID have predominantly focussed on compar-
ing individuals with intellectual disability with and with-
out autism, with variable results regarding whether autism 
increases the rates of anxiety disorders, although these stud-
ies have been relatively small (Bakken et al. 2010; Bradley 
and Bolton 2006; Charlot et al. 2008; Gillott and Standen 
2007). There is relatively more evidence on this issue in 
the literature on children and adolescents. For example, in 
their meta-analysis, van Steensel et al. found that studies of 
children and adolescents with ASD with a lower mean IQ 
had higher rates of social anxiety and generalised anxiety 
disorder, whilst studies with a higher mean IQ had higher 
prevalence of separation anxiety and OCD (lower and higher 
defined by the cross study mean of 87) (van Steensel et al. 
2011). Only one study reported a mean IQ < 70 in which 
higher anxiety scores were associated with higher IQ and the 
presence of functional language use, however not for sim-
ple phobia, panic disorder and social phobia (Sukhodolsky 
et al. 2008). Further information on whether the risk of being 
diagnosed with anxiety disorders in the autistic population 
differs by the presence or absence of intellectual disability 
is therefore warranted.
It is possible that ASD and anxiety are associated through 
shared genetic causes. Genetic variants with pleiotropic 
effects on the ASD and anxiety phenotypes have been iden-
tified (Geschwind 2011) and family-based studies suggest 
aggregation of ASD in offspring to parents with anxiety 
disorders (Meier et al. 2015; Duvekot et al. 2016) as well 
as aggregation of anxiety in family members of individuals 
with ASD or autistic traits (Bolton et al. 1998; Jokiranta-
Olkoniemi et al. 2016). However, the associations found 
in family-based studies may also reflect the psychological 
burden of having a close family member with ASD or dif-
ficulties in social interaction or communication.
In as far as ASD and anxiety are genetically linked, one 
could expect risk of anxiety to vary with genetic distance 
from the ASD proband, as it has been observed for family 
history (Xie et al. 2019). That is, risk of anxiety disorders 
would be highest in ASD cases, lower in their non-autistic 
full siblings (with whom they share on average 50% of their 
genome), lower still in their non-autistic half-siblings (with 
whom they share only 25% of their genome) and lowest in 
a non-autistic reference population (to whom they are likely 
unrelated). Comparing risks in this way can therefore help 
to explore a potential genetic correlation between autism 
and anxiety.
An additional advantage to the sibling design is that it 
allows for the direct comparison of ASD probands with non-
autistic sibling controls, with whom they are likely to share 
many potentially confounding characteristics. Since associa-
tions within sibling pairs will not be confounded by charac-
teristics that are shared between them (e.g. early life envi-
ronment), sibling comparisons can account for unobserved 
confounders and may thereby provide a better estimate of 
causal effects when using observational data.
Using data from a large population-based cohort, this 
study aimed to: (1) describe the lifetime prevalence of diag-
nosed anxiety disorders in addition to prevalence in those 
aged 18 and over in people with ASD; (2) compare the 
risk of diagnosis of anxiety disorders in young adulthood 
among those with ASD (any; with ID; without ID) with that 
in a non-autistic reference population; (3) compare risk for 
diagnosis of anxiety disorders across ASD cases; their full 
siblings; their half-siblings; and a reference population; and 
(4) compare risk of anxiety disorders in adults with ASD 




The Stockholm Youth Cohort (SYC) is a register based 
cohort of all individuals who lived in Stockholm County, 
Sweden, for at least 1 year between January 1st 2001 and 
December 31st 2011 and were aged between 0 and 17 years 
at any time during that period (n = 736,180) (Idring et al. 
2012, 2015). All residents in Sweden receive a unique 
personal identification number at birth or on immigration 
to Sweden, which enables the collection of prospectively 
recorded data via a number of national and regional health 
care, social and administrative registers (Idring et al. 2012). 
Statistics Sweden carried out the record linkages and, before 
the research group were given access, a serial number was 
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used to replace the personal identity number to ensure the 
anonymity of cohort members. For this study, we excluded 
adoptees, those whose biological parents could not be iden-
tified, and those with missing covariate data. Over 96% of 
those with missing data were attributable to individuals 
or their parents having been born abroad, indicating their 
absence from Sweden and thus having missing informa-
tion in the registers. Considering < 5% were excluded due 
to missing data, and there was no evidence of a difference 
between anxiety disorder diagnoses in those with or without 
missing data (p = 0.14), bias due to missing data is unlikely 
in this study. We included those who had been in the cohort 
over 4 years at the end of follow-up on December 31st 2011 
for the analysis of lifetime prevalence (Supplement Figure 
I) and in the main analysis excluded anyone who was under 
the age of 18 (Fig. 1). After exclusions, our study popula-
tion consisted of 221,694 aged ≥ 18 years, of whom 4049 
had been diagnosed with ASD. We also identified the full 
and half-siblings of individuals with ASD within our study 
population. The study was approved by the ethical review 
board of Karolinska Institutet, Stockholm.
Identification of ASD
ASD diagnoses were established using national and regional 
registers that encompass all known pathways for ASD diag-
nosis and follow-up in Stockholm County. We obtained diag-
noses of ASD (ASD: ICD-9 299, ICD-10 F84, DSM-IV 299) 
and intellectual disability (ID: ICD-9 317-319, ICD-10 F70-
79, DSM-IV 317-319), identifying individuals with ASD 
without ID and with ID within our study population and 
additionally used service use data to identify ASD and intel-
lectual disability (Idring et al. 2012, 2015). This method has 
been shown to have good validity in identifying individuals 
with a diagnosis of ASD (Idring et al. 2012) and provides 
comprehensive coverage of in-patient, out-patient and pri-
mary care contacts in this population.
Identification of Anxiety Disorders
For the purpose of this study, we included neurotic, stress 
related and somatoform disorders as defined in the World 
Health Organisation’s ICD-10 as our outcomes. We used 
three registers to identify members of the cohort who 
received a diagnosis of anxiety disorder by a clinician dur-
ing the time period studied. These include the (1) National 
patient register, which contains the dates and discharge 
diagnoses of all inpatients in Sweden since 1973, and 
outpatient care since 2001; (2) the Stockholm adult psy-
chiatric outpatient register which records the dates and 
diagnoses for any contact with specialist outpatient psy-
chiatric services in Stockholm County since 1997; and (3) 
the Stockholm child and adolescent mental health register 
(PASTILL) which records dates and diagnoses of all child 
and adolescent mental health care in Stockholm County 
since 1999. The majority of the mental health services in 
Sweden are publicly funded with diagnoses contempora-
neously recorded using ICD-10 codes in the relevant reg-
isters. Clinicians follow international and national guide-
lines when making such diagnoses, although individual 
variation in the diagnostic process is likely and the details 
of measures or tools used are not recorded in the regis-
ters. Diagnoses recorded in Swedish registers have been 
extensively used in psychiatric epidemiology and several 
validation studies on a range of psychiatric diagnoses have 
been carried out including obsessive compulsive disorders 
(Ludvigsson et al. 2011; Ruck et al. 2015; Allebeck 2009). 
We used the adult and child diagnostic registers to enable 
us to assess lifetime prevalence in addition to prevalence in 
those over 18 years of age. We then stratified our primary 
outcome variable (any anxiety disorder: ICD-10 F40-48) 
by diagnostic subtype to identify specific disorders as 
detailed in Supplement Table 1.
Fig. 1  Selection procedure for 
the study population n =736,180
n = 572, 068
Younger than 18 years at follow-up (n= 336, 125)
Adoptee or missing link to biological parents (n= 13, 242)
n = 235, 943
Missing covariate data (n= 1, 007)
n = 222, 701
n = 221, 694
Less than 4 years of follow-up (n= 164, 112)
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Covariates
We identified variables that, in the literature, have been 
associated with ASD as well as anxiety. These include the 
individual’s age and sex, parental age at birth, highest educa-
tion of either parent (≤ 9 years, 10–12, ≥ 13 years), quintile 
of household income, individual or parental birth country 
outside of Sweden, and having a record of parental mental 
illness (Lofors et al. 2006; de Graaf et al. 2002; Rai et al. 
2012; Jokiranta et al. 2013).
Statistical Analysis
Analyses were performed in Stata/MP version 14.2. We 
examined the characteristics of our study cohort by exposure 
status (no ASD; any ASD, further dichotomised into ASD 
with and without ID) in relation to the outcomes. We then 
used modified Poisson regression to estimate the relative risk 
(RR) of being diagnosed with an anxiety disorder after the 
age of 18 among those with a diagnosis of ASD (any; with 
ID; without ID) compared with a non-autistic reference pop-
ulation, using robust standard errors to account for clustering 
of outcomes within families. We compared the relative risk 
estimates for anxiety disorder diagnosis for adults with ASD 
with and without comorbid ID in supplementary analysis. In 
supplementary analysis we also calculated the prevalence of 
anxiety disorders for those with ASD (any; with ID; without 
ID) for the full population of those aged 4–27 years of age. 
To explore a potential genetic gradient, we also estimated the 
relative risk of anxiety disorders among the non-autistic full- 
and half-siblings of ASD cases compared with a non-autistic 
reference population using the same methods (but cluster-
ing on maternal rather than family identification number for 
half-siblings), and compared these relative risk estimates 
in supplementary analysis. We adjusted our estimates for 
(1) sex and age at the end of follow-up, and additionally 
for (2) parental age, parental educational attainment, fam-
ily disposable income quintile, individual or parental for-
eign birth, and maternal and paternal psychiatric history. 
To assess the extent to which associations between ASD 
and anxiety were due to unobserved shared familial con-
founders, we directly compared adult individuals with ASD 
with their discordant full sibling controls using conditional 
logistic regression models with adjustment for non-shared 
characteristics between sibling pairs (age, birth order, sex, 
maternal and paternal age). Lastly, as anxiety disorders are 
known to be a common problem in children with ASD (van 
Steensel et al. 2011), we wanted to assess whether anxiety 
disorders in adults were a continuation of these, or a separate 
clinical issue which requires its own consideration. For this 
reason, we identified the relative risk of a new diagnosis 
of an anxiety disorder in adulthood in people with no pre-
vious history of an anxiety disorder as this could provide 
clinically relevant information for clinicians working with 
adults. As further clinically useful information, in a sup-
plementary analysis, we calculated the average age of onset 
of these anxiety disorders and the proportion of the sample 
diagnosed with anxiety before and/or after the age of 18.
Results
Our cohort contained 221,694 individuals aged 18 to 
27 years of whom 4049 had been diagnosed with ASD. 
We provide study characteristics and descriptive statistics 
by ASD case status, including the lifetime prevalence of a 
diagnosis of specific types of anxiety disorders, in Table 1. 
Just over a fifth (20.13%) of adults with ASD had also been 
diagnosed with an anxiety disorder compared with 8.72% of 
an adult non-autistic reference population (adjusted RR 2.62 
[95% CI 2.47–2.79]), and prevalence of anxiety disorder was 
highest in the absence of comorbid ID (23.11%) (Tables 1 
and 2). 
The most common diagnostic labels were non-specific, 
with 5.91% of the reference population and 10.16% of adults 
with ASD having a diagnosis of “other stress related disor-
ders” or a non-specific anxiety disorder diagnosis, which 
fell under our category label of “other neurotic or anxiety 
disorder” (Table 1). Except for “other stress-related disor-
ders”, people with ASD had higher relative risks for receiv-
ing a diagnosis of all types of anxiety disorder compared 
to a non-autistic reference population (Table 2). Amongst 
the common anxiety disorder diagnoses, prevalence of OCD 
diagnoses was notably raised in people with ASD (3.43%) 
compared with the general population (0.47%) (adjusted RR 
8.07 [95% CI 6.74–9.65]) and prevalence of phobic anxiety 
disorders was also markedly higher. This increase can be 
partly accounted for by an increased prevalence of social 
phobia for adults with ASD; however, there were also higher 
rates of all other phobic anxiety disorders. The relative risk 
of developing a dissociative disorder for an adult with ASD 
was also high; however, the numbers of individuals with this 
disorder were low, leading to very wide confidence intervals.
There was a clear difference between the rates of anxi-
ety disorders diagnosed in adults with ASD associated with 
the presence or absence of intellectual disability (Table 2). 
The relative risk for an anxiety disorder diagnosis for adults 
with ASD without ID was almost three times higher than the 
general population (adjusted RR 2.96 [95% CI 2.77–3.16]), 
higher than the same estimate for adults with ASD with ID 
(adjusted RR 1.71 [95% CI 1.47–1.99]) (Table 2), with evi-
dence of a statistical difference in these estimates (p < 0.001, 
Supplement Table 3). Adults with ASD without ID had 
higher adjusted risks of panic disorder, generalised anxiety 
disorder, PTSD, somatoform disorders and mixed anxiety 
and depression, trends which were not present for those with 
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ASD and ID. Rates of diagnoses of specific phobias, such as 
social phobia and agoraphobia were also higher for adults 
with ASD without ID, whereas adults with ASD who had 
ID were more likely to receive the non-specific diagnosis of 
‘other phobia’. Mixed anxiety and depression, adjustment 
disorders and acute stress reactions were diagnoses which 
were more common in adults with ASD both with and with-
out ID compared to the non-autistic reference population.
Comparing the ASD cases with their non-autistic full- 
and half-siblings, risk of anxiety disorder was highest 
amongst the ASD cases than their full- and half-siblings, 
and risks were raised in siblings compared with the gen-
eral population. However, we did not observe a consistent 
gradient in risk with increased genetic distance (Table 3) 
although there was some evidence of such a difference in 
ASD without ID (p = 0.021, Supplement Table 4). Risk for 
anxiety among cases was highest in the absence of comorbid 
ID, although risk of anxiety among siblings did not appear 
to vary with being the family member of person with ASD 
with or without ID.
We then directly compared risk of anxiety in adults with 
ASD with risk in their discordant non-autistic full siblings 
using a conditional logistic model. Cases with ASD had a 
higher risk of anxiety disorders compared with their dis-
cordant non-autistic full siblings (adjusted OR 2.48 [95% 
CI 2.06–3.01]) suggesting that associations were robust 
against confounding from factors shared between siblings. 
Associations were stronger among full siblings discordant 
for ASD without comorbid ID (adjusted OR 3.10 [95% CI 
2.50–3.85]). Amongst siblings discordant for ASD with 
Table 1  Characteristics of the total study population (age 18–27) by ASD diagnosis and ASD with and without intellectual disability
GAD generalised anxiety disorder, OCD obsessive–compulsive disorder, PTSD post-traumatic stress disorder










 Age range 18–27. Mean (sd) 22.66 (2.86) 21.97 (2.71) 21.95 (2.68) 22.04 (2.80)
 Male sex (%) 50.89 65.94 64.44 69.76
 Mother’s age at birth. Mean (sd) 28.64 (5.27) 29.16 (5.64) 29.03 (5.59) 29.47 (5.75)
 Father’s age at birth. Mean (sd) 31.71 (6.32) 32.08 (6.70) 31.83 (6.64) 32.72 (6.80)
 Parental education < 9 years (%) 9.46 8.22 7.26 10.69
 Family income in lowest quintile (%) 22.45 19.51 17.64 24.28
 Individual or their parents born outside Swe-
den (%)
35.05 31.39 28.37 39.09
 Maternal psychiatric history (%) 35.03 49.49 51.86 43.47
 Paternal psychiatric history (%) 22.90 31.51 32.26 29.62
Prevalence % (n)
All anxiety disorders 8.72 (18,980) 20.13 (815) 23.11 (672) 12.53 (143)
 All phobic anxiety disorders 0.90 (1968) 3.75 (152) 4.71 (137) 1.31 (15)
  Social phobia 0.63 (1369) 3.04 (123) 3.95 (115) 0.70 (8)
  Agoraphobia 0.23 (508) 0.74 (30) 0.93 (27) 0.26 (3)
  Specific phobia 0.10 (213) 0.20 (8) 0.24 (7) 0.09 (1)
  Other phobia 0.05 (115) 0.27 (11) 0.14 (4) 0.61 (7)
 Panic disorder 1.69 (3688) 2.91 (118) 3.44 (100) 1.58 (18)
 GAD 0.60 (1304) 1.65 (67) 2.06 (60) 0.61 (7)
 OCD 0.47 (1017) 3.43 (139) 3.85 (112) 2.37 (27)
 Acute stress reaction 0.70 (1524) 1.98 (80) 2.30 (67) 1.14 (13)
 PTSD 0.30 (643) 0.74 (30) 0.93 (27) 0.26 (3)
 Adjustment disorders 0.42 (919) 1.28 (52) 1.41 (41) 0.96 (11)
 Other stress-related disorders 2.23 (4861) 2.03 (82) 2.34 (68) 1.23 (14)
 Dissociative disorder 0.04 (88) 0.32 (13) 0.21 (6) 0.61 (7)
 Somatoform disorders 0.25 (546) 0.62 (25) 0.72 (21) 0.35 (4)
 Mixed anxiety/depression 1.31 (2860) 4.74 (192) 5.85 (170) 1.93 (22)
 Other neurotic or anxiety disorder 3.68 (7999) 8.13 (329) 9.28 (270) 5.17 (59)
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Table 2  Relative risk of a diagnosis of anxiety disorder between ages 18 and 27 years in individuals with ASD, and ASD with or without ID 
compared to the general population
GAD generalised anxiety disorder, OCD obsessive–compulsive disorder, PTSD post-traumatic stress disorder, RR relative risk, CI confidence 
interval
a Modified Poisson regression with cluster robust standard errors. Model 1 adjusted for age and sex
b Model 2 adjusted for age, sex, maternal and paternal age, parental educational attainment, family disposable income quintile, individual or 
parental migration, and maternal and paternal psychiatric history















2.95 (2.78–3.14) 2.62 (2.47–2.79) 3.38 (3.16–3.60) 2.96 (2.77–3.16) 1.87 (1.60–2.17) 1.71 (1.47–1.99)
All phobic anxiety 
disorders
5.19 (4.41–6.10) 4.54 (3.85–5.35) 6.48 (5.48–7.67) 5.57 (4.69–6.61) 1.84 (1.11–3.04) 1.68 (1.01–2.79)
 Social phobia 5.86 (4.88–7.03) 5.07 (4.21–6.10) 7.60 (6.30–9.16) 6.46 (5.34–7.82) 1.35 (0.68–2.70) 1.23 (0.61–2.45)
 Agoraphobia 4.10 (2.84–5.91) 3.53 (2.44–5.11) 5.10 (3.47–7.49) 4.31 (2.92–6.36) 1.49 (0.48–4.62) 1.35 (0.44–4.21)
 Specific phobia 3.00 (1.49–6.07) 2.77 (1.37–5.59) 3.61 (1.70–7.64) 3.28 (1.55–6.93) 1.40 (0.20–9.93) 1.34 (0.19–9.57)
 Other phobia 6.48 (3.50–12.01) 5.99 (3.20–11.19) 3.29 (1.21–8.97) 2.98 (1.10–8.10) 14.92 (7.03–31.66) 13.93 (6.51-29.78)
Panic disorder 2.20 (1.84–2.63) 1.97 (1.65–2.37) 2.58 (2.13–3.14) 2.29 (1.89–2.80) 1.20 (0.76–1.90) 1.11 (0.70–1.76)
GAD 3.68 (2.88–4.69) 3.17 (2.48–4.05) 4.55 (3.52–5.87) 3.84 (2.97–4.97) 1.39 (0.66–2.90) 1.27 (0.61–2.65)
OCD 9.11 (7.64–10.85) 8.07 (6.74–9.65) 10.21 (8.43–12.38) 8.88 (7.28–10.82) 6.24 (4.28–9.10) 5.78 (3.96–8.44)
Acute stress reac-
tion
3.71 (2.97–4.64) 3.24 (2.58–4.07) 4.30 (3.38–5.47) 3.72 (2.91–4.75) 2.17 (1.26–3.73) 1.93 (1.12-3.31)
PTSD 3.47 (2.41–5.00) 2.98 (2.06–4.32) 4.27 (2.91–6.26) 3.66 (2.48–5.39) 1.28 (0.41–3.96) 1.10 (0.36–3.44)
Adjustment dis-
orders
3.98 (3.02–5.25) 3.49 (2.65–4.60) 4.37 (3.20–5.95) 3.79 (2.78–5.17) 3.01 (1.66–5.44) 2.73 (1.51–4.93)
Other stress-related 
disorders
1.26 (1.02–1.57) 1.11 (0.90–1.38) 1.45 (1.15–1.84) 1.26 (1.00–1.60) 0.78 (0.46–1.31) 0.70 (0.42–1.18)
Dissociative 
disorder
11.02 (6.13–19.81) 10.12 (5.59–18.32) 6.94 (3.04–15.82) 6.45 (2.76–15.08) 22.04 (10.11–48.02) 20.42 (9.46–44.11)
Somatoform dis-
orders
3.11 (2.08–4.65) 2.93 (1.95–4.41) 3.64 (2.35–5.64) 3.42 (2.20–5.33) 1.75 (0.65–4.68) 1.64 (0.62–4.40)
Mixed anxiety/
depression
4.65 (4.03–5.36) 3.98 (3.45–4.60) 5.66 (4.88–6.57) 4.75 (4.08–5.53) 1.95 (1.29–2.96) 1.76 (1.16–2.67)
Other neurotic or 
anxiety disorder
2.88 (2.59–3.19) 2.53 (2.28–2.81) 3.28 (2.93–3.67) 2.84 (2.54–3.19) 1.85 (1.44–2.36) 1.68 (1.32–2.15)
Table 3  Relative risk (95% CI) for a diagnosis of an anxiety disorder among those diagnosed with ASD, their siblings and half-siblings, com-
pared with population controls
RR relative risk, CI confidence interval
a Modified Poisson regression with cluster robust standard errors. Model 1 adjusted for age and sex
b Model 2 adjusted for age, sex, maternal and paternal age, parental educational attainment, family disposable income quintile, foreign birth of 
child or parents, and maternal and paternal psychiatric history
Cases versus population controls Siblings of cases versus population 
controls














All ASD 2.95 (2.78–3.14) 2.62 (2.47–2.79) 1.50 (1.38–1.64) 1.37 (1.26–1.49) 1.48 (1.31–1.68) 1.22 (1.07–1.38)
ASD without ID 3.38 (3.16–3.60) 2.96 (2.77-3.16) 1.59 (1.44–1.76) 1.41 (1.28–1.57) 1.41 (1.22–1.62) 1.15 (1.00–1.33)
ASD with ID 1.87 (1.60–2.17) 1.71 (1.47–1.99) 1.32 (1.11–1.56) 1.28 (1.08–1.51) 1.77 (1.37–2.28) 1.48 (1.14–1.92)
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comorbid ID there did not appear to be an association 
between ASD diagnosis and anxiety disorder (adjusted OR 
1.04 [95% CI 0.71–1.54]).
The mean age of diagnosis for all anxiety disorders was 
just under the age of 15 for people with ASD and just under 
the age of 17 for people without ASD (Supplement Table 5). 
However, our research found that even when there had been 
no history of a childhood anxiety disorder (66% of all ASD 
cases), adults with ASD continued to be at higher risk of 
being diagnosed with an anxiety disorder compared to 
adults without ASD (adjusted RR 2.71 [95% CI 2.52–2.91]) 
and this risk was highest for people with ASD without 
ID (adjusted RR 3.13 [95% CI 2.90–3.38]) (Supplement 
Tables 6 and 7).
Discussion
In this large population based study in Sweden, we found 
that people with ASD were over two and a half times more 
likely to have a diagnosis of an anxiety disorder than a refer-
ence population without ASD, and risk appeared highest for 
people with ASD without intellectual disability.
There are only a few epidemiological studies with which 
we can directly compare our results. Our findings of higher 
rates of anxiety disorders in general and OCD specifically 
are consistent with evidence in adults found in previous stud-
ies (Croen et al. 2015; Meier et al. 2015). This is the first 
large, population-based study which has assessed the rates 
of PTSD in adults with ASD. This is consistent with a large 
study of autistic traits amongst nursing staff which found 
that PTSD rates were highest amongst those in the highest 
quintile for autistic traits (10.7%) versus those in the low-
est quintile for autistic traits (4.5%) (Roberts et al. 2015). 
Previous research has additionally suggested that traumatic 
childhood events are associated with developmental disor-
ders, including ASD, but that low reported rates of PTSD in 
youth with ASD may be due to diagnosis being complicated 
by individuals with ASD manifesting symptoms of traumatic 
stress in a distinct manner from individuals without ASD 
(Kerns et al. 2015).
It is of note that the most commonly used diagnostic 
labels for all individuals were those identifying a non-spec-
ified anxiety or neurotic disorder, which we termed “other 
neurotic or anxiety disorder”, and there were a significantly 
greater number of individuals with ASD being given the 
diagnosis of “other phobias” than the general population. 
This may be due to specific disorders or phenomenology 
being harder to distinguish in individuals with ASD, or due 
to multiple phobic anxiety disorders being present which 
may complicate the diagnostic picture. To our knowledge 
this is the first study to measure somatoform disorder and 
dissociative disorder in individuals with ASD, and our study 
found significantly higher rates of these conditions.
Higher rates of anxiety disorders in people with ASD may 
occur for a number of reasons (Kerns and Kendall 2012). For 
example, people with ASD may be more likely to experience 
peer rejection and prevention or punishment of their desired 
behaviours (for example restricted, repetitive interests). 
Additionally, social difficulties such as repeated experiences 
of misinterpreting social situations or communication lead-
ing to misunderstandings may produce anxiety, particularly 
in social situations. In typically developing adolescents and 
those with ASD, social difficulties have been associated 
with increased anxiety (Bellini 2006) and in particular an 
individual’s perception of their social skills difficulties is 
predictive of social anxiety (Bellini 2004). The impact of 
social stressors may be increased by a biological vulner-
ability to anxiety. For example, limbic system dysfunction 
and behavioural inhibition are associated with both ASD and 
anxiety disorders. Lower arousal thresholds in the amygdala 
associated with behavioural inhibition may in turn result in 
people with ASD avoiding and being conditioned by nega-
tive experiences (Bellini 2006). Sensory over-responsivity 
has also been suggested as a possible cause of anxiety dis-
order in ASD (Mazurek et al. 2013), causing problematic 
fears to develop as a result of increased sensitivity to certain 
stimuli. In OCD, whilst obsessional thoughts are common in 
the general population, it has been suggested that the cogni-
tive deficits associated with ASD may influence the man-
ner in which these thoughts are appraised, resulting in more 
anxiety and the development of OCD (Russell et al. 2005).
To our knowledge this is the first study of the difference 
in prevalence rates of anxiety disorders for adults with ASD 
with and without ID. The finding of higher rates of anxiety 
disorders amongst adults with ASD without ID compared 
with adults with ASD and ID is consistent with some of the 
results from studies of children with ASD and anxiety dis-
order (Weisbrot et al. 2005; Sukhodolsky et al. 2008; Mayes 
et al. 2011) and with a recent study of depression in ASD 
(Rai et al. 2018), and may be due to a number of factors. 
Increased rates of anxiety disorders may be present in indi-
viduals without ID due to increased cognitive awareness of 
their impairments (Bauminger et al. 2003). It may also be 
that the rates of anxiety disorder in people with ASD and 
ID are underestimated due to carers or clinicians attributing 
features of anxiety as a symptom of an individual’s ID, also 
known as diagnostic overshadowing. We found higher rates 
of “other phobias” in individuals with ASD and ID, con-
sistent with studies in youth, where ID was associated with 
more “atypical” versus “traditional” anxiety features (Kerns 
et al. 2014). Additionally, given that many anxiety symptoms 
are associated with increased verbal ability, the absence of 
an ID and associated increase in verbal skills may play a key 
role in the ability to communicate anxiety symptoms. This 
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is consistent with studies in children and adolescents where 
the presence of functional language use has been associated 
with an increase in anxiety symptoms in children with ASD 
(Sukhodolsky et al. 2008), and has been shown to have an 
opposite pattern to children without ASD, where language 
deficits were associated with increased anxiety symptoms, 
suggesting a unique relationship between ASD, language 
and anxiety (Davis et al. 2011).
Assessing the risk of anxiety disorders in full- and half-
siblings of individuals can be a useful tool to help find gra-
dients in risk that may be influenced by genetic loading. 
Our results did not identify any evidence of risk gradients 
between full- and half-siblings of individuals with ASD; 
however, there was an increased risk of an anxiety disorder 
diagnosis for siblings and half-siblings compared with the 
general population. Studies of full-siblings of children and 
young adults with ASD have found a comparable increased 
risk of anxiety disorders (Jokiranta-Olkoniemi et al. 2016). 
However, we were not able to control for the situations such 
as parental separation which may contribute to higher rates 
of anxiety disorders in all half-siblings, possibly masking 
a gradient. While the increased risk of anxiety in siblings 
may still suggest the role of common genetic vulnerability, 
siblings of children with ASD may also be prone to psychi-
atric disorders through other mechanisms. For example, they 
may receive less parental attention because of their autistic 
sibling having more needs or may experience other stressors 
in the household. The sibling control analysis allowed us to 
directly compare the risk of anxiety disorder in individu-
als with ASD versus their discordant siblings. This enabled 
additional control of shared-environmental and shared-
genetic confounding factors. The notably higher rates in 
adults with ASD compared with their discordant siblings 
gives additional evidence for the prospect of genetic factors 
specifically related to ASD, or other ASD-specific environ-
mental factors that increase vulnerability to anxiety disor-
ders, which could be possible targets for future interventions.
This study highlights that anxiety disorders are a signifi-
cant problem for adults with autism and there is therefore 
a need for effective evidence-based treatments. Cognitive-
behavioural therapy (CBT) is the most researched therapy 
for anxiety disorders in individuals with ASD; however, 
whilst there is a growing volume of research supporting the 
use of CBT for anxiety in children and adolescents with 
ASD, less is known about the use of CBT in adults with 
ASD (Rosen et  al. 2018). Concerning pharmacological 
treatments, current evidence suggests that selective seroto-
nin re-uptake inhibitors (SSRIs) produce benefit in anxiety 
disorders in ASD, including to obsessional thoughts (Buchs-
baum et al. 2001; McDougle et al. 1996) and compulsions 
(Hollander et al. 2012; McDougle et al. 1996). However, 
studies have been small and the overall evidence for phar-
macological treatments is also limited (Howes et al. 2018).
The results of this study should be interpreted in the 
light of the following limitations. Firstly, as this is a reg-
ister based study, the possibility of exposure and outcome 
misclassification cannot be ruled out. There may be undiag-
nosed people with ASD in the population which could lead 
to some exposure misclassification. If this were differential 
in relation to the outcome, for example, if those with greater 
anxiety symptoms were more likely to be diagnosed with 
ASD more easily, then our observed associations may be 
over-estimates of the true association. If the reverse were 
true or the misclassification was not differential, then the 
results would likely be biased towards the null. Likewise, it 
is likely there are individuals with anxiety disorders in our 
cohort who have not been recorded as such. Due to the use 
of registers we were also not able to verify the anxiety disor-
der diagnoses. This may be an important limitation as there 
are phenomenological differences in presentation of anxi-
ety disorders in individuals with ASD and/or ID and there 
may be potential variability between clinicians and mental 
health care centres in their recognition. The possibility of 
such measurement error may be compounded by the lack of 
standardised tools available for the measurement of anxiety 
disorders within the ASD population. Such misclassification 
may have been somewhat minimised by our use of anxi-
ety disorder diagnoses from secondary care and inpatient 
records which are made by specialists, although it should be 
noted that there are still no clear consensus guidelines for 
measuring anxiety in ASD. Although the majority of diag-
noses of specific anxiety disorders such as OCD would be 
made in secondary care, primary care doctors are involved in 
diagnosing anxiety disorders, particularly generalised anxi-
ety disorder and mixed anxiety and depression; this means 
that the rates of these conditions within our study may be 
underestimated. Therefore, the possibility of outcome mis-
classification cannot be ruled out. Such limitations would 
be common to any record-linkage study and cohort studies 
with detailed clinical information would need to be carried 
out to assess this further. We were unable to measure early 
life trauma, which is a limitation as it may be associated with 
ASD (Kerns et al. 2015) and with anxiety disorders, particu-
larly the higher rates of PTSD. Despite these limitations, 
this study has several strengths. The Swedish registers are 
of high quality, enabling a large sample size with the ability 
to adjust for a range of confounders and examine siblings 
of individuals with ASD. The prospective data collection 
minimises the possibility of recall bias.
Conclusion
Anxiety disorders are a notable problem for people with 
ASD. It is important for adult mental health services to be 
skilled at working with this population where co-occurring 
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anxiety is so prevalent. More research is needed to deter-
mine the causes of increased anxiety for people with ASD. 
Our findings suggest a potential for environmental pathways; 
however, delineating these further may help the develop-
ment of preventative interventions or targeted treatment. 
Our study has identified increased rates of specific anxiety 
disorders for adults with ASD which has been explored in 
children and adolescents but not studied previously in adults 
and these associations need to be replicated in future stud-
ies. Future research is also needed to better understand the 
phenomenology of anxiety disorders in this population and 
to better the means of measuring and treating anxiety in 
this population. This may be an aim worth pursuing because 
effective management of anxiety in this population could 
lead to major gains in quality of life and functioning (Kerns 
and Kendall 2012).
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